RecruitingNCT05184790

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Sponsor

University of Sydney

Enrollment

300 participants

Start Date

Feb 28, 2023

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Liver Cancer Pancreatic Cancer Head and Neck Cancer Prostatic Cancer Kidney Cancer Brain Cancer Arrhythmias, Cardiac Spinal Neoplasm

Summary

This study will develop a whole-of-body markerless tracking method for measuring the motion of the tumour and surrounding organs during radiation therapy to enable real-time image guidance. Routinely acquired patient data will be used to improve the training, testing and accuracy of a whole-of-body markerless tracking method. When the markerless tracking method is sufficiently advanced, according to the PI of each of the data collection sites, the markerless tracking method will be run in parallel to, but not intervening with, patient treatments during data acquisition.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting imaging data from cancer patients receiving radiation therapy to train and test artificial intelligence (AI) tools that can help improve the precision and efficiency of radiation treatment planning and delivery. **You may be eligible if:** - You are 18 years or older - You are receiving radiation therapy for brain, breast, head and neck, kidney, liver, pancreas, prostate, spine cancer, or for a heart rhythm condition at a participating center - You will receive CT-based radiation planning and at least one cone beam CT scan during treatment - You are willing to give written informed consent **You may NOT be eligible if:** - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.